- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The β-Nicotinamide Mononucleotide (NMN) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global β-Nicotinamide Mononucleotide (NMN) market size is estimated to be worth US$ 262.7 million in 2021 and is forecast to a readjusted size of USD 451.3 million by 2028 with a CAGR of 8.0% during review period. Health Care Products accounting for % of the β-Nicotinamide Mononucleotide (NMN) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Above 98% segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of β-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, and Maac10 Formulas, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
β-Nicotinamide Mononucleotide (NMN) market is split by Content and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Content and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Content, covers
Above 98%
Below 98%
Market segment by Application can be divided into
Health Care Products
Cosmetics
Others
The key market players for global β-Nicotinamide Mononucleotide (NMN) market are listed below:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe β-Nicotinamide Mononucleotide (NMN) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of β-Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of β-Nicotinamide Mononucleotide (NMN) from 2019 to 2022.
Chapter 3, the β-Nicotinamide Mononucleotide (NMN) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the β-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Content and application, with sales market share and growth rate by content, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and β-Nicotinamide Mononucleotide (NMN) market forecast, by regions, content and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of β-Nicotinamide Mononucleotide (NMN).
Chapter 13, 14, and 15, to describe β-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 β-Nicotinamide Mononucleotide (NMN) Introduction
1.2 Market Analysis by Content
1.2.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content: 2017 Versus 2021 Versus 2028
1.2.2 Above 98%
1.2.3 Below 98%
1.3 Market Analysis by Application
1.3.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global β-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume (2017-2028)
1.4.3 Global β-Nicotinamide Mononucleotide (NMN) Price (2017-2028)
1.5 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity Analysis
1.5.1 Global β-Nicotinamide Mononucleotide (NMN) Total Production Capacity (2017-2028)
1.5.2 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 β-Nicotinamide Mononucleotide (NMN) Market Drivers
1.6.2 β-Nicotinamide Mononucleotide (NMN) Market Restraints
1.6.3 β-Nicotinamide Mononucleotide (NMN) Trends Analysis
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 β-Nicotinamide Mononucleotide (NMN) Breakdown Data by Manufacturer
3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in β-Nicotinamide Mononucleotide (NMN)
3.4 Market Concentration Rate
3.4.1 Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2021
3.4.2 Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2021
3.5 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and β-Nicotinamide Mononucleotide (NMN) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2017-2028)
4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028)
4.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.3 Europe β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.4 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.5 South America β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.6 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
5 Market Segment by Content
5.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Content (2017-2028)
5.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2028)
5.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Content (2017-2028)
6 Market Segment by Application
6.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Application (2017-2028)
6.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028)
6.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2028)
7 North America by Country, by Content, and by Application
7.1 North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
7.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
7.3 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
7.3.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Content, and by Application
8.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
8.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
8.3 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
8.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Content, and by Application
9.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
9.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
9.3 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Content, and by Application
10.1 South America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
10.2 South America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
10.3 South America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
10.3.2 South America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Content, and by Application
11.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
11.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
11.3 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of β-Nicotinamide Mononucleotide (NMN) and Key Manufacturers
12.2 Manufacturing Costs Percentage of β-Nicotinamide Mononucleotide (NMN)
12.3 β-Nicotinamide Mononucleotide (NMN) Production Process
12.4 β-Nicotinamide Mononucleotide (NMN) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 β-Nicotinamide Mononucleotide (NMN) Typical Distributors
13.3 β-Nicotinamide Mononucleotide (NMN) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content, (USD Million), 2017 & 2021 & 2028
Table 2. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 6. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 8. Herbalmax Major Business
Table 9. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 10. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 12. Genex Formulas Major Business
Table 13. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 14. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Shinkowa Pharmaceutical Major Business
Table 17. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 18. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 20. Maac10 Formulas Major Business
Table 21. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 22. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. EffePharm Basic Information, Manufacturing Base and Competitors
Table 24. EffePharm Major Business
Table 25. EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 26. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bontac Basic Information, Manufacturing Base and Competitors
Table 28. Bontac Major Business
Table 29. Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 30. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CELFULL Basic Information, Manufacturing Base and Competitors
Table 32. CELFULL Major Business
Table 33. CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 34. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 36. Kingdomway Major Business
Table 37. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 38. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 40. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in β-Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Company, (Kg): 2020 VS 2021
Table 43. Head Office and β-Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
Table 44. β-Nicotinamide Mononucleotide (NMN) New Entrant and Capacity Expansion Plans
Table 45. β-Nicotinamide Mononucleotide (NMN) Mergers & Acquisitions in the Past Five Years
Table 46. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 47. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
Table 48. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (USD Million)
Table 49. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (USD Million)
Table 50. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
Table 51. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
Table 52. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2022) & (USD Million)
Table 53. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2023-2028) & (USD Million)
Table 54. Global β-Nicotinamide Mononucleotide (NMN) Price by Content (2017-2022) & (US$/Kg)
Table 55. Global β-Nicotinamide Mononucleotide (NMN) Price by Content (2023-2028) & (US$/Kg)
Table 56. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 57. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 58. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (USD Million)
Table 59. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (USD Million)
Table 60. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) & (US$/Kg)
Table 61. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2023-2028) & (US$/Kg)
Table 62. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 63. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
Table 64. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (USD Million)
Table 65. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (USD Million)
Table 66. North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
Table 67. North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
Table 68. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 69. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 70. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 71. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
Table 72. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
Table 75. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
Table 76. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 77. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 78. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 79. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
Table 80. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
Table 83. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
Table 84. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 85. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 86. South America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 87. South America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
Table 88. South America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (USD Million)
Table 89. South America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (USD Million)
Table 90. South America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
Table 91. South America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
Table 92. South America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 93. South America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 94. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 95. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
Table 96. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
Table 99. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
Table 100. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 101. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 102. β-Nicotinamide Mononucleotide (NMN) Raw Material
Table 103. Key Manufacturers of β-Nicotinamide Mononucleotide (NMN) Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. β-Nicotinamide Mononucleotide (NMN) Typical Distributors
Table 107. β-Nicotinamide Mononucleotide (NMN) Typical Customers
List of Figures
Figure 1. β-Nicotinamide Mononucleotide (NMN) Picture
Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content in 2021
Figure 3. Above 98%
Figure 4. Below 98%
Figure 5. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2021
Figure 6. Health Care Products
Figure 7. Cosmetics
Figure 8. Others
Figure 9. Global β-Nicotinamide Mononucleotide (NMN) Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 10. Global β-Nicotinamide Mononucleotide (NMN) Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Sales (2017-2028) & (Kg)
Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Price (2017-2028) & (US$/Kg)
Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (2017-2028) & (Kg)
Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. β-Nicotinamide Mononucleotide (NMN) Market Drivers
Figure 16. β-Nicotinamide Mononucleotide (NMN) Market Restraints
Figure 17. β-Nicotinamide Mononucleotide (NMN) Market Trends
Figure 18. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturer in 2021
Figure 19. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturer in 2021
Figure 20. β-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2021
Figure 23. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 24. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2028)
Figure 25. North America β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 26. Europe β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 28. South America β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
Figure 31. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2028)
Figure 32. Global β-Nicotinamide Mononucleotide (NMN) Price by Content (2017-2028) & (US$/Kg)
Figure 33. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 34. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
Figure 35. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2028) & (US$/Kg)
Figure 36. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
Figure 37. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 38. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2028)
Figure 39. North America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2028)
Figure 40. United States β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
Figure 44. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 45. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2028)
Figure 46. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2028)
Figure 47. Germany β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2028)
Figure 56. China β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
Figure 63. South America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 64. South America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2028)
Figure 65. South America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2028)
Figure 66. Brazil β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
Figure 69. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2028)
Figure 72. Turkey β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of β-Nicotinamide Mononucleotide (NMN) in 2021
Figure 77. Manufacturing Process Analysis of β-Nicotinamide Mononucleotide (NMN)
Figure 78. β-Nicotinamide Mononucleotide (NMN) Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
